Clinical characteristics and treatment outcome of adult acute lymphoblastic leukemia with t(4;11)(q21;q23) using a modified hyper-CVAD regimen.
Li
Yenan
Y
Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
Zou
Dehui
D
Zhao
Yaozhong
Y
Wang
Jianxiang
J
Qiu
Lugui
L
D000293:Adolescent; D000328:Adult; D003520:Cyclophosphamide / Q000627:therapeutic use*; D003907:Dexamethasone / Q000627:therapeutic use*; D015251:Epirubicin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000235:genetics; D016896:Treatment Outcome; D014751:Vindesine / Q000627:therapeutic use*
D015251:Epirubicin; D003907:Dexamethasone; D003520:Cyclophosphamide; D014751:Vindesine